Immunology

New peanut allergy treatment shows effectiveness and safety

People allergic to peanuts may have a new way to protect themselves from severe allergic reactions to accidental peanut exposure. It's called sublingual immunotherapy—or SLIT—and it involves putting a miniscule amount ...

Immunology

Increasing cases of anaphylaxis among children

Anaphylaxis, known to be a sudden and potentially life-threatening allergic reaction, seems to be increasing among children, according to a new study led by a team at the Research Institute of the McGill University Health ...

Obstetrics & gynaecology

Anaphylaxis is rare complication of pregnancy

(HealthDay)—Anaphylaxis is a rare complication of pregnancy, with an estimated incidence of 1.6 per 100,000 maternities, according to a study published online Nov. 29 in BJOG: An International Journal of Obstetrics and ...

Immunology

Structured education program beneficial for anaphylaxis

(HealthDay)—A structured education intervention improves knowledge and emergency management for patients at risk for anaphylaxis and their caregivers, according to a study published online Nov. 19 in Allergy.

page 1 from 23

Anaphylaxis is defined as "a serious allergic reaction that is rapid in onset and may cause death". It typically results in a number of symptoms including an itchy rash, throat swelling, and low blood pressure. Common causes include insect bites, foods, and medications.

On a pathophysiologic level, anaphylaxis is due to the release of mediators from certain types of white blood cells triggered either by immunologic or non-immunologic mechanisms. It is diagnosed based on the presenting symptoms and signs. The primary treatment is injection of epinephrine, with other measures being complementary.

Worldwide 0.05–2% of people are estimated to have anaphylaxis at some point in their life and rates appear to be increasing. The term comes from the Greek words ἀνά ana, against, and φύλαξις phylaxis, protection.

This text uses material from Wikipedia licensed under CC BY-SA